Citation Impact 2023
Journal Impact Factor: 6.1
5-year Journal Impact Factor: 7.1
Source Normalized Impact per Paper (SNIP): 1.865
SCImago Journal Rank (SJR): 2.578
Speed 2023
Submission to first editorial decision (median days): 14
Submission to acceptance (median days): 129
Usage 2023
Downloads: 2,432,781
Altmetric mentions: 1,561
Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer
Breast cancer is the most common cancer in women diagnosed in the U.S. and worldwide. Obesity increases breast cancer risk without clear underlying molecular mechanisms. Our studies demonstrate that circulatin...